Stocktoria
ATOSSA THERAPEUTICS, INC. ATOS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-11-08
ATOSSA THERAPEUTICS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Steinhart Richard I | director | 2026-05-12 | Grant | 10,000 | — |
| Chen Shu-Chih | director | 2026-05-12 | Grant | 10,000 | — |
| Remmel H. Lawrence | director | 2026-05-12 | Grant | 10,000 | — |
| Finn Jonathan | director | 2026-05-12 | Grant | 10,000 | — |
| Galli Stephen J | director | 2026-05-12 | Grant | 10,000 | — |
| Cigler Tessa | director | 2026-05-12 | Grant | 10,000 | — |
| QUAY STEVEN C | President & CEO | 2026-03-27 | Grant | 65,000 | — |
| Daniel Mark James | Chief Financial Officer | 2026-03-26 | Grant | 63,000 | — |
Source: SEC EDGAR filings · CIK 0001488039 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.